What top creators are saying about Dupixent(DUPIXENT)
Prescription biologic medicine for inflammatory diseases, marketed by Sanofi and Regeneron.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about Dupixent.
Top creators covering Dupixent (DUPIXENT)
The 1 sources with the most insights about Dupixent on Kazuha.
Latest insights about Dupixent (DUPIXENT)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Yesterday
The speaker cited impending generic competition and loss of exclusivity as a potential risk for the product.
Yesterday
The speaker cited impending generic competition and loss of exclusivity as a potential risk for the product.
Discussed alongside Dupixent (DUPIXENT)
Other assets that creators frequently mention in the same content as Dupixent.
Frequently asked
Which podcasters and creators cover Dupixent (DUPIXENT) the most?
The most active sources covering Dupixent (DUPIXENT) on Kazuha are @theshkrelipill. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Dupixent (DUPIXENT) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Dupixent (DUPIXENT) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Dupixent (DUPIXENT)?
Creators covering Dupixent (DUPIXENT) most frequently also discuss DELL, ASML, BTC, LQDA, CTVA. See the "Discussed alongside" section above for full asset pages.